# US Absorbable Heart Stent Market > US Absorbable Heart Stent Market Research Report By Material (Metal, Polymer), By Application (Coronary Artery Disease, Periphery Artery Disease) and By End-Use (Hospitals, Clinics, Cardiovascular Centers, Research Institutes and Organizations, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.05% - **2024:** $ 2.08 Million - **2025:** $ 2.22 Million - **2035:** $ 4.39 Million - **Key Players:** Abbott (US), Boston Scientific (US), Medtronic (US), Biotronik (DE), Terumo (JP), Janssen Pharmaceuticals (US), B. Braun (DE), Stentys (FR) **Report ID:** MRFR/MED/18311-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-absorbable-heart-stent-market-19858 --- ## Market Summary ## **US Absorbable Heart Stent Market Overview** ### **Key US Absorbable Heart Stent Market Trends Highlighted** As per MRFR analysis, the US Absorbable Heart Stent Market Size was estimated at 23.81 (USD Million) in 2023. The US Absorbable Heart Stent Market Industry is expected to grow from 27.5(USD Million) in 2024 to 169 (USD Million) by 2035. The US Absorbable Heart Stent Market CAGR (growth rate) is expected to be around 17.947% during the forecast period (2025 - 2035). The US Absorbable Heart Stent Market has been trending towards increased adoption and innovation in recent years. One major driver is the rising prevalence of coronary artery disease, which has motivated healthcare providers to explore advanced treatment options such as absorbable stents. These stents offer the benefit of temporary support to the arterial wall, allowing for natural vessel healing while minimizing long-term complications. As awareness regarding the advantages of absorbable stents grows, more patients and physicians are opting for these devices over traditional metallic stents. In terms of opportunities, there is a considerable potential for research and development in the US. The ongoing advancements in biocompatible materials and drug-eluting technologies present avenues for companies to improve stent performance and patient outcomes. Additionally, with healthcare policies in the US promoting minimally invasive procedures and cost-effective treatments, companies developing absorbable stents may find favorable conditions for market entry and expansion. Recently, there has been a noticeable trend towards the integration of digital health solutions that accompany the use of absorbable stents. Technologies such as remote monitoring and data analytics not only enhance patient management but can also influence the design of future stents. Regulatory bodies in the US are also working towards streamlined approval processes for innovative medical devices, further fostering a conducive environment for the growth of the absorbable heart stent market. Collectively, these trends indicate a dynamic shift in cardiac care, emphasizing patient-centered approaches and technological advancements to improve treatment efficacy and safety. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Absorbable Heart Stent Market Drivers** ### **Increasing Cardiovascular Disease Incidence** Cardiovascular diseases continue to be one of the leading causes of death in the United States, accounting for approximately 697,000 deaths in 2020 alone, according to the Centers for Disease Control and Prevention (CDC). This growing prevalence of heart-related ailments significantly drives the US [Absorbable Heart Stent Market](../../../reports/absorbable-heart-stent-market-1175) Industry, as absorbable stents are increasingly preferred due to their temporary presence in the blood vessel. As the American Heart Association (AHA) projects a significant rise in cardiovascular incidences, with an increase of about 10% over the next decade, the adoption of absorbable stents is expected to grow accordingly. The heightened focus on advanced treatment options, fueled by the aging population and lifestyle changes, encourages healthcare providers to invest in innovative solutions like absorbable stents. Additionally, organizations like the Food and Drug Administration (FDA) have been progressively approving more absorbable stent technologies, thereby facilitating market expansion. ### **Technological Advancements in Stent Design** Recent advancements in material science and engineering have paved the way for improved design and functionality of absorbable heart stents in the US. The innovation within the US Absorbable Heart Stent Market Industry is driven by Research and Development (R&D) efforts from major [medical device companies](../../../reports/africa-medical-devices-market/companies) like Abbott Laboratories and Boston Scientific, who collectively hold a large market share and are responsible for a multitude of patents in stent technology. The emergence of new biodegradable materials promises better biocompatibility and reduced risk of inflammation, which supports patient recovery significantly. As the FDA continues to highlight innovations through its regulatory pathways, a 12% increase in patent filings related to absorbable stents over the last three years suggests a robust inclination towards investment and innovation, fueling market growth. ### **Rising Geriatric Population** The demographic trend in the United States indicates a rapidly increasing geriatric population, which is particularly susceptible to cardiovascular diseases. By 2030, it's estimated that 20% of the US population will be 65 years or older, based on the U.S. Census Bureau projections. This demographic shift boosts the US Absorbable Heart Stent Market Industry demand, as older adults often require more complex cardiovascular treatments. The improved accessibility to absorbable stents in hospitals and healthcare facilities, coupled with positive clinical outcomes highlighting reduced complications, promotes their adoption among healthcare providers caring for older populations. Organizations such as the National Institute on Aging continuously focus on advancing geriatric care strategies, which will contribute to the growth of the absorbable heart stent market to accommodate this patient base. ### **Growing Awareness about Minimally Invasive Procedures** There is a growing trend among both healthcare professionals and patients in the United States towards minimally invasive procedures due to their efficiency and reduced recovery time. The US Absorbable Heart Stent Market Industry benefits uniquely from this trend, as absorbable stents significantly improve procedural outcomes with a less invasive approach compared to traditional stents. According to the American College of Cardiology, minimally invasive cardiac procedures have seen an uptick in adoption rate of over 15% in recent years, with rising patient preference for techniques that minimize scarring and hospital stays. This healthcare paradigm shift, supported by various leading cardiology associations advocating for less invasive solutions, creates a conducive environment for the growth of absorbable heart stents in the US market. ## **US Absorbable Heart Stent Market Segment Insights** ### **Absorbable Heart Stent Market Material Insights** The US Absorbable Heart Stent Market has witnessed considerable growth, particularly in the Material segment, focusing on advancements in materials such as Metal and Polymer. These materials play a crucial role in the development and efficacy of absorbable heart stents, which serve the essential purpose of providing support to arteries while gradually dissolving after fulfilling their function. On the other hand, Polymer-based stents are gaining traction due to their tailored bio-absorbable properties, allowing for a more controlled degradation pattern which is significant in minimizing long-term complications and improving patient outcomes. The growing prevalence of cardiovascular diseases in the US drives the demand for innovative heart stent solutions, subsequently enhancing the importance of different materials used in their manufacturing. Additionally, advances in material science have enabled the development of composite materials that combine the best attributes of both Metal and Polymer, potentially paving the way for hybrid designs that further push the boundaries of stent technology. Market trends indicate a growing preference for these high-performance materials, as research institutes and hospitals advocate for stents that provide better healing rates and reduced re-occlusion rates, which are essential tenets in the treatment of coronary artery disease. The US Absorbable Heart Stent Market segmentation emphasizes that both Metal and Polymer materials are vital for addressing the needs of an aging population with increasing heart-related issues. Despite their differing properties, both materials contribute significantly to the overall effectiveness and safety of absorbable heart stents. For instance, Metal stents might be favored for situations requiring immediate structural support, while Polymer counterparts can be essential in cases where gradual absorption at a controlled rate is critical for patient recovery. Furthermore, government initiatives and healthcare reforms in the US strongly favor the adoption of innovative medical technologies, which further validates the growth trajectory of the US Absorbable Heart Stent Market. These initiatives exemplify overarching trends prioritizing patient safety and improved health outcomes, setting the stage for further advancements in patient-specific stent design based on Material selections. Challenges such as ensuring compatibility with body tissues and achieving optimal absorption timelines remain, but they also present opportunities for continuous innovation within the industry. Overall, the Material segment is a cornerstone for the ongoing evolution of the US Absorbable Heart Stent Market, reflecting both the complexities of cardiovascular health and the potential for medical innovation to enhance patient care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Absorbable Heart Stent Market Application Insights** The Application segment of the US Absorbable Heart Stent Market plays a crucial role in addressing various cardiovascular conditions, notably Coronary Artery Disease and Peripheral Artery Disease. Coronary Artery Disease, caused by the buildup of plaque in the coronary arteries, is a leading cause of heart attacks in the United States. As healthcare professionals seek to enhance patient outcomes, the use of these stents is gaining traction. On the other hand, Peripheral Artery Disease is characterized by narrowed arteries reducing blood flow to limbs, impacting mobility and quality of life for many patients. The growing prevalence of lifestyle-related conditions, such as obesity and diabetes, has led to an increased focus on developing effective treatments, with absorbable stents emerging as a significant option. Collectively, these applications represent key avenues for growth within the US Absorbable Heart Stent Market, driven by evolving patient needs and advancements in medical technology. The emphasis on minimally invasive procedures and patient-centered care continues to foster momentum for these innovative devices in the cardiovascular landscape. ### **Absorbable Heart Stent Market End-Use Insights** The US Absorbable Heart Stent Market demonstrates substantial segmentation in the End-Use category, which comprises various healthcare facilities critical for managing cardiovascular diseases. Hospitals take precedence in this segment due to their advanced infrastructure and patient care capabilities, often being the primary endpoint for procedures involving absorbable stents. Additionally, Research Institutes and Organizations contribute through extensive research and development, enhancing the efficacy and safety of these stents. The growing frequency of coronary artery diseases in the US fuels demand across these diverse facilities, leading to increased investments and opportunities for market growth. Overall, each segment within End-Use provides unique contributions to refining patient outcomes in the US Absorbable Heart Stent Market while highlighting the interconnectedness of healthcare services in addressing cardiovascular health. ## **US Absorbable Heart Stent Market Key Players and Competitive Insights** The competitive landscape of the US Absorbable Heart Stent Market reveals a dynamic and rapidly evolving environment characterized by significant innovation and strategic partnerships among leading players. The market has attracted attention due to its potential for transformative treatment solutions in cardiac care, particularly for patients with coronary artery disease. Major companies in this sector are focusing on the development of advanced technologies that enhance stent performance, promote faster healing, and minimize complications associated with traditional metal stents. Competitive strategies often include a combination of research and development initiatives, regulatory approvals, and targeted marketing efforts aimed at healthcare providers and institutions. This competitive insight indicates a robust market where companies are continuously striving to improve patient outcomes while navigating the regulatory landscape and addressing the growing demand for minimally invasive procedures. Janssen Pharmaceuticals has carved out a significant presence in the US Absorbable Heart Stent Market by leveraging its extensive research capabilities and commitment to innovative solutions in cardiovascular therapies. The company is recognized for its strength in developing advanced medical technologies aimed at optimizing patient safety and treatment efficacy. Janssen's strategic approach often encompasses collaborations with healthcare professionals and stakeholders, allowing for valuable insights into patient needs and clinical outcomes. This engagement has fostered strong relationships that enhance the company’s reputation within the cardiac care community. As a part of a larger pharmaceutical organization, Janssen benefits from substantial resources that facilitate the introduction of pioneering products in the marketplace, enabling it to maintain a competitive edge in the absorptive stent sector. Edwards Lifesciences enjoys a prominent position in the US Absorbable Heart Stent Market, characterized by its innovative solutions and high-quality products in heart valve therapies and vascular interventions. The company has established a solid reputation for pioneering technologies that integrate both absorbable and conventional stent designs, contributing to enhanced patient care in cardiovascular treatments. Edwards Lifesciences' strengths lie in its comprehensive product pipeline that addresses diverse cardiovascular conditions, coupled with a robust market presence bolstered by strategic mergers and acquisitions aimed at expanding its technological capabilities. The company actively invests in research and development, ensuring that its stent offerings are aligned with the latest developments in medical science. Through these efforts, Edwards Lifesciences continues to solidify its leadership role within the US Absorbable Heart Stent Market, demonstrating adaptability and innovation to meet evolving patient and healthcare provider demands. ### **Key Companies in the US Absorbable Heart Stent Market Include** ## **US Absorbable Heart Stent Market Industry Developments** The US Absorbable Heart Stent Market has seen significant developments, particularly with companies like Janssen Pharmaceuticals, Edwards Lifesciences, and Abbott Laboratories leading in innovation. In June 2023, Edwards Lifesciences announced advancements in their absorbable stent technologies, which aim to enhance patient outcomes and reduce complications. Additionally, in August 2023, Medtronic launched a new clinical trial for its absorbable stent product line, intending to gather data that could pave the way for regulatory approvals and market expansion. Notably, in terms of mergers and acquisitions, in July 2023, Boston Scientific acquired a smaller firm specializing in biocompatible materials for their stent products, thereby boosting their manufacturing capabilities and strengthening their portfolio. Overall, growth in valuations for companies like Gore Medical and Stryker Corporation has been driven by increased investment in Research and Development, reflecting a broader trend towards minimally invasive solutions in cardiac care. Major happenings over the last couple of years include FDA approvals for several innovative stent designs, increasing the interest of hospital networks in adopting next-generation absorbable technologies, further solidifying the market’s trajectory in the US. ## **US Absorbable Heart Stent Market Segmentation Insights** ### **Absorbable Heart Stent Market Material Outlook** ### **Absorbable Heart Stent Market Application Outlook** ### **Absorbable Heart Stent Market End-Use Outlook** ## Market Drivers ### Supportive Reimbursement Policies Reimbursement policies play a crucial role in the adoption of new medical technologies, including absorbable heart-stents. In the US, favorable reimbursement frameworks for innovative cardiovascular devices are emerging, which may encourage healthcare providers to adopt these stents more widely. Insurance companies are increasingly recognizing the long-term cost savings associated with absorbable stents, as they may reduce the need for repeat procedures and associated healthcare costs. The absorbable heart-stent market stands to benefit from these supportive policies, which could lead to a projected market growth of approximately 20% over the next five years, as financial barriers diminish. ### Increasing Awareness and Education There is a growing awareness among healthcare professionals and patients regarding the benefits of absorbable heart-stents. Educational initiatives and outreach programs are being implemented to inform stakeholders about the advantages of these devices, such as reduced long-term complications and improved patient outcomes. As more clinicians become familiar with the technology, the adoption rate is likely to increase, thereby driving the absorbable heart-stent market. The absorbable heart-stent market is expected to see a rise in utilization rates, potentially reaching 30% of all stent procedures in the coming years, as patients and providers alike recognize the value of these innovative solutions. ### Rising Cardiovascular Disease Prevalence The increasing incidence of cardiovascular diseases in the US is a primary driver for the absorbable heart-stent market. According to the CDC, heart disease remains the leading cause of death, accounting for approximately 697,000 fatalities annually. This alarming statistic underscores the urgent need for innovative treatment options, such as absorbable stents, which offer a temporary solution that dissolves over time, reducing long-term complications. As healthcare providers seek effective interventions, the demand for absorbable heart-stents is likely to rise, potentially leading to a market growth rate of around 15% annually. The absorbable heart-stent market is thus positioned to benefit from this growing patient population requiring advanced cardiovascular care. ### Technological Innovations in Stent Design Advancements in stent technology are significantly influencing the absorbable heart-stent market. Innovations such as bioresorbable polymers and improved drug-eluting capabilities enhance the performance and safety of these devices. Recent studies indicate that the use of absorbable stents can lead to lower rates of restenosis compared to traditional metal stents. The absorbable heart-stent market is witnessing a surge in research and development efforts, with companies investing heavily in creating stents that not only dissolve but also deliver therapeutic agents effectively. This focus on technological enhancement is expected to propel market growth, with projections suggesting a potential increase in market size to over $2 billion by 2027. ### Aging Population and Demand for Minimally Invasive Solutions The aging population in the US is driving the demand for minimally invasive medical solutions, including absorbable heart-stents. As individuals age, the risk of cardiovascular diseases increases, necessitating effective treatment options that minimize recovery time and complications. Absorbable stents offer a less invasive alternative to traditional stenting procedures, appealing to both patients and healthcare providers. The absorbable heart-stent market is likely to experience growth as the demographic shift continues, with estimates suggesting that by 2030, nearly 20% of the US population will be over 65 years old, further amplifying the need for innovative cardiovascular interventions. ## Future Outlook The [Absorbable Heart Stent Market](https://www.marketresearchfuture.com/reports/absorbable-heart-stent-market-1175) is projected to grow at a 7.05% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures. **New opportunities:** - Development of biodegradable stents with enhanced biocompatibility Expansion into telehealth platforms for remote patient monitoring Strategic partnerships with hospitals for exclusive stent supply agreements By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased adoption. ## Segment Insights ### By Material: Metal (Largest) vs. Polymer (Fastest-Growing) In the US absorbable heart-stent market, the Metal segment holds the largest market share due to its established presence and reliability in clinical applications. This segment benefits from a long history of successful usage, which fosters healthcare providers' trust in metal-based stents. Conversely, the Polymer segment, while currently smaller in terms of market share, is rapidly gaining traction as innovative materials are developed, enhancing biocompatibility and other functional properties. The growth trends for these segments indicate a shift towards the Polymer segment as advancements in technology pave the way for novel stent designs. The increasing demand for less invasive procedures is also driving this change, as absorbable polymer stents can promote healing and reduce complications. Additionally, rising investments in R&D for improved materials are expected to further enhance the Polymer segment's position in the market, making it the fastest-growing option. Material: Metal (Dominant) vs. Polymer (Emerging) The Metal segment dominates the US absorbable heart-stent market due to its proven efficacy and safety profile in numerous cardiovascular interventions. These stents offer robust structural support, which is crucial during the healing process. However, the Polymer segment is emerging as a strong competitor, characterized by its innovative designs that allow for gradual absorption into the body. This creates opportunities for enhanced patient outcomes as Polymer stents often result in reduced long-term complications. The ongoing research and development in materials science are expected to bolster the performance metrics of Polymer stents, making them increasingly attractive in clinical practices. ### By Application: Coronary Artery Disease (Largest) vs. Periphery Artery Disease (Fastest-Growing) In the realm of the absorbable heart-stent market, Coronary Artery Disease (CAD) holds the largest share, attributed to its higher incidence rates and established treatment protocols. It is recognized that CAD stenting is widely practiced, leading to a robust demand, as healthcare providers increasingly opt for absorbable stents to enhance patient outcomes while minimizing long-term complications. Conversely, the Periphery Artery Disease (PAD) segment is identified as the fastest-growing sector within this market. The rising prevalence of PAD, influenced by lifestyle factors and an aging population, contributes significantly to this growth. Increased awareness and advancements in medical technology further drive the adoption of absorbable stents in managing peripheral artery interventions, bridging a critical gap in treatment options available for patients suffering from PAD. Application: Coronary Artery Disease (Dominant) vs. Periphery Artery Disease (Emerging) Coronary Artery Disease (CAD) is recognized as the dominant segment in the absorbable heart-stent market, primarily due to the high volume of surgical procedures performed annually and ongoing innovations in stenting technology. CAD stents tend to have rigorous clinical backing and established usage protocols, making them a preferred choice among healthcare practitioners. In contrast, Periphery Artery Disease (PAD) is emerging with increasing recognition by medical professionals and patients alike. This segment benefits from a growing focus on comprehensive cardiovascular care and innovative stenting solutions designed specifically for peripheral arteries. As awareness grows and technologies advance, PAD is expected to gain a larger market foothold. ### By End-user: Hospitals & clinics (Largest) vs. Cardiovascular centres (Fastest-Growing) In the US absorbable heart-stent market, hospitals & clinics hold the largest share due to their extensive patient base and advanced treatment capabilities. This segment is followed by cardiovascular centres, which are gaining a significant market presence owing to their specialized services and dedicated facilities for heart-related treatments. Medical research institutes & organizations contribute to the market but are less dominant, often supporting development rather than being direct end-users. Others include outpatient facilities that play a minor role in the overall market dynamics. Growth trends indicate an increasing adoption of absorbable heart-stents driven by technological advancements and a growing awareness of minimally invasive procedures. Hospitals & clinics are rapidly enhancing their service offerings, while cardiovascular centres are emerging as key players due to rising patient volumes and a focus on specialized care. This trend is further fueled by increasing collaborations between manufacturers and healthcare providers aimed at improving patient outcomes and optimizing treatment protocols. Hospitals & clinics (Dominant) vs. Cardiovascular centres (Emerging) Hospitals & clinics dominate the US absorbable heart-stent market, benefiting from their capacity to handle a large volume of procedures and a continuous influx of patients requiring cardiac interventions. Their well-established infrastructure and access to the latest technology enable them to provide timely and effective treatments. Conversely, cardiovascular centres are emerging with a focus on specialized, high-quality care, often providing comprehensive cardiovascular services that attract patients seeking expert treatment. This segment is expanding rapidly, supported by increased funding, patient referrals, and a trend towards specialization in healthcare, establishing itself as a critical component of the market. ## Competitive Benchmarking The absorbable heart-stent market is currently characterized by a dynamic competitive landscape, driven by innovation, regulatory advancements, and increasing patient demand for less invasive cardiovascular solutions. Key players such as Abbott (US), Boston Scientific (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Abbott (US) focuses on technological innovation, particularly in bioresorbable stent technology, while Boston Scientific (US) emphasizes strategic partnerships to expand its product offerings. Medtronic (US) is actively pursuing mergers and acquisitions to bolster its portfolio, indicating a trend towards consolidation in the market. Collectively, these strategies contribute to a competitive environment that is increasingly centered on advanced technology and patient-centric solutions.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market appears moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This competitive structure allows for a diverse range of products and innovations, catering to varying patient needs and preferences. In October Abbott (US) announced the successful completion of a clinical trial for its latest absorbable stent, which reportedly demonstrated improved patient outcomes compared to traditional metal stents. This development not only reinforces Abbott's commitment to innovation but also positions the company to capture a larger share of the market as healthcare providers increasingly seek effective and less invasive treatment options. The strategic importance of this trial lies in its potential to enhance Abbott's reputation as a leader in cardiovascular technology. In September Boston Scientific (US) entered into a partnership with a leading digital health company to integrate AI-driven analytics into its stent monitoring systems. This collaboration aims to provide real-time data to healthcare providers, thereby improving patient management and outcomes. The strategic significance of this partnership is evident, as it aligns with the growing trend of digitalization in healthcare, positioning Boston Scientific to leverage technology for enhanced patient care. In August Medtronic (US) completed the acquisition of a European firm specializing in bioresorbable materials, which is expected to accelerate its product development timeline for absorbable stents. This acquisition underscores Medtronic's strategy to enhance its technological capabilities and expand its product range. The implications of this move are profound, as it not only strengthens Medtronic's market position but also reflects a broader trend of consolidation within the industry. As of November the competitive trends in the absorbable heart-stent market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, shaping the landscape as companies seek to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, advanced technology, and supply chain reliability, indicating a shift in how companies will compete in this vital sector. ## Recent News & Developments The US Absorbable Heart Stent Market has seen significant developments, particularly with companies like Janssen Pharmaceuticals, Edwards Lifesciences, and Abbott Laboratories leading in innovation. In June 2023, Edwards Lifesciences announced advancements in their absorbable stent technologies, which aim to enhance patient outcomes and reduce complications. Additionally, in August 2023, Medtronic launched a new clinical trial for its absorbable stent product line, intending to gather data that could pave the way for regulatory approvals and market expansion. Notably, in terms of mergers and acquisitions, in July 2023, Boston Scientific acquired a smaller firm specializing in biocompatible materials for their stent products, thereby boosting their manufacturing capabilities and strengthening their portfolio. Overall, growth in valuations for companies like Gore Medical and Stryker Corporation has been driven by increased investment in Research and Development, reflecting a broader trend towards minimally invasive solutions in cardiac care. Major happenings over the last couple of years include FDA approvals for several innovative stent designs, increasing the interest of hospital networks in adopting next-generation absorbable technologies, further solidifying the market’s trajectory in the US. ## Report Scope | MARKET SIZE 2024 | 2.08(USD Million) | | --- | --- | | MARKET SIZE 2025 | 2.22(USD Million) | | MARKET SIZE 2035 | 4.39(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.05% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott (US), Boston Scientific (US), Medtronic (US), Biotronik (DE), Terumo (JP), Janssen Pharmaceuticals (US), B. Braun (DE), Stentys (FR) | | Segments Covered | Material, Application, End-user | | Key Market Opportunities | Advancements in biocompatible materials enhance performance in the absorbable heart-stent market. | | Key Market Dynamics | Technological advancements drive innovation in absorbable heart-stents, enhancing patient outcomes and regulatory compliance. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US absorbable heart-stent market in 2024?** A: The market valuation was $2.08 Million in 2024. **Q: What is the projected market valuation for the US absorbable heart-stent market in 2035?** A: The projected valuation for 2035 is $4.39 Million. **Q: What is the expected CAGR for the US absorbable heart-stent market during the forecast period 2025 - 2035?** A: The expected CAGR is 7.05% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the US absorbable heart-stent market?** A: Key players include Abbott, Boston Scientific, Medtronic, Biotronik, Terumo, Janssen Pharmaceuticals, B. Braun, and Stentys. **Q: What are the main material segments in the US absorbable heart-stent market?** A: The main material segments are Metal and Polymer, with valuations of $1.04 Million and $2.21 Million respectively. **Q: How does the US absorbable heart-stent market perform in terms of application segments?** A: In terms of application, Coronary Artery Disease generated $1.46 Million, while Periphery Artery Disease accounted for $0.62 Million. **Q: What are the end-user segments for the US absorbable heart-stent market?** A: End-user segments include Hospitals & Clinics at $0.83 Million, Medical Research Institutes at $0.42 Million, and Cardiovascular Centres at $0.63 Million. **Q: What is the projected growth trend for the US absorbable heart-stent market?** A: The market appears to be on a growth trajectory, with a projected increase to $4.39 Million by 2035. **Q: What was the valuation of the Polymer segment in the US absorbable heart-stent market in 2024?** A: The Polymer segment was valued at $1.04 Million in 2024. **Q: How does the market for absorbable heart-stents compare between 2024 and 2035?** A: The market is expected to grow from $2.08 Million in 2024 to $4.39 Million in 2035, indicating robust growth. **Q: What is the projected market size for the US Absorbable Heart Stent Market by 2035?** A: By 2035, the US Absorbable Heart Stent Market is projected to reach a value of 169.0 million USD. **Q: What is the anticipated compound annual growth rate (CAGR) for the US Absorbable Heart Stent Market from 2025 to 2035?** A: The expected CAGR for the US Absorbable Heart Stent Market from 2025 to 2035 is 17.947%. **Q: Which material segment is expected to dominate the US Absorbable Heart Stent Market?** A: The polymer material segment is expected to dominate the market, valued at 16.5 million USD in 2024. **Q: What is the estimated market value of the metal segment in the US Absorbable Heart Stent Market by 2035?** A: The market value of the metal segment is projected to reach 68.0 million USD by 2035. **Q: Who are the major players in the US Absorbable Heart Stent Market?** A: Major players in the market include Janssen Pharmaceuticals, Edwards Lifesciences, and Boston Scientific among others. **Q: What growth opportunity exists for the US Absorbable Heart Stent Market?** A: The growing demand for minimally invasive procedures presents significant growth opportunities in the market. **Q: How might changes in healthcare regulations impact the US Absorbable Heart Stent Market?** A: Changes in healthcare regulations could pose challenges or create opportunities for market expansion and innovation. **Q: What applications are driving the growth of the US Absorbable Heart Stent Market?** A: The demand for advanced cardiac stenting procedures is driving growth in the market. **Q: What factors are influencing the competition in the US Absorbable Heart Stent Market?** A: Innovation in material technology and competitive pricing strategies are key factors influencing market competition. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-absorbable-heart-stent-market-19858*